Kotak Investment Advisors Limited (KIAL), the alternative assets arm of Kotak Mahindra Group, said it has invested Rs 940 crore ($109.4 million) in India’s Neuberg Diagnostics, as it readies itself to list on the Indian bourses.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
